Association of polymorphisms in folate metabolic genes and prostate cancer risk: A case-control study in a Chinese population

Journal of Genetics

Volumn 89, Issue 2, 2010, Pages 263-267

  Cai, Dawei ^a   Ning, Lin ^b   Pan, Chunyu ^a   Liu, Xuefeng ^a   Bu, Renge ^a   Chen, Xiaonan ^a   Wang, Kefeng ^a   Cheng, Yang ^c   Wu, Bin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c Shenyang First People's Hospital   (China)

Author keywords

folate metabolic genes; haplotype; human genetics; polymorphisms; prostate cancer

Indexed keywords

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; FOLIC ACID; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINA; GENETIC LINKAGE; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PROSTATE HYPERTROPHY; PROSTATE TUMOR; SINGLE NUCLEOTIDE POLYMORPHISM;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CHINA; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENETIC LINKAGE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 78349291482     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-010-0037-7     Document Type: Article

References (21)

1. Bailey L. and Gregory J. 1999 Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J. Nutr. 129, 919-922.
2. Choi S. and Mason J. 2000 Folate and carcinogenesis: an integrated scheme. J. Nutr. 130, 129-132.
3. Cicek M., Nock N., Li L., Conti D., Casey G. and Witte J. 2004 Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cancer Epidemiol. Biomarkers Prevent. 13, 1331-1336.
4. Collin S. M., Metcalfe C., Zuccolo L., Lewis S. J., Chen L., Cox A. et al. 2009 Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol. Biomarkers Prevent. 18, 2528-2539.
5. Duthie S. 1999 Folic acid deficiency and cancer: mechanisms of DNA instability. Br. Med. Bull. 55, 578-592.
6. Figueiredo J., Grau M., Haile R., Sandler R., Summers R., Bresalier R. et al. 2009 Folic acid and risk of prostate cancer: results from a randomized clinical trial. J. Natl. Cancer Inst. 101, 432-435.
7. Frosst P., Blom H., Milos R., Goyette P., Sheppard C., Matthews R. et al. 1995 A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10, 111-113.
8. Heijmans B., Boer J., Suchiman H., Cornelisse C., Westendorp R., Kromhout D. et al. 2003 A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res. 63, 1249-1253.
9. Johansson M., van Guelpen B., Hultdin J., Wiklund F., Adami H., Bälter K. et al. 2007 The MTHFR 677C → T polymorphism and risk of prostate cancer: results from the CAPS study. Cancer Causes Control18, 1169-1174.
10. Leclerc D., Campeau E., Goyette P., Adjalla C., Christensen B., Ross M. et al. 1996 Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum. Mol. Genet. 5, 1867-1874.
11. Marchal C., Redondo M., Reyes-Engel A., Perea-Milla E., Gaitan M., Machuca J. et al. 2008 Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer. Eur. J. Surg. Oncol. 34, 805-810.
12. Nelson W., De Marzo A. and Isaacs W. 2003 Prostate cancer. N. Engl. J. Med. 349, 366-381.
13. Pelucchi C., Galeone C., Talamini R., Negri E., Parpinel M., Franceschi S. et al. 2005 Dietary folate and risk of prostate cancer in Italy. Cancer Epidemiol. Biomarkers Prevent. 14, 944-948.
14. Reljic A., Simundic A., Topic E., Nikolac N., Justinic D. and Stefanovic M. 2007 The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study. Clin. Biochem. 40, 981-985.
15. Shen H., Newmann A., Hu Z., Zhang Z., Xu Y., Wang L. et al. 2005 Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China. Oncol. Rep. 13, 355-360.
16. Singal R., Ferdinand L., Das P., Reis I. and Schlesselman J. 2004 Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. Int. J. Oncol. 25, 1465-1471.
17. Suzuki T., Matsuo K., Hiraki A., Saito T., Sato S., Yatabe Y. et al. 2007 Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. Carcinogenesis28, 1718-1725.
18. van Guelpen B., Wirén S., Bergh A., Hallmans G., Stattin P. and Hultdin J. 2006 Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study. Eur. J. Cancer Prev. 15, 46-50.
19. Wei Q., Shen H., Wang L., Duphorne C., Pillow P., Guo Z. et al. 2003 Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol. Biomarkers Prevent. 12, 963-969.
20. Weisberg I., Jacques P., Selhub J., Bostom A., Chen Z., Curtis Ellison R. et al. 2001 The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis156, 409-415.
21. Weisberg I., Tran P., Christensen B., Sibani S. and Rozen R. 1998 A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 64, 169-172.